/2796.T
2796.T Stock - Pharmarise Holdings Corporation
Healthcare|Medical - PharmaceuticalsJPX
$531.00+0.38%
+$2.00 (+0.38%) • Dec 24
69
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.59
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $584.10
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for 2796.T
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$525.69 – $536.31
TARGET (TP)$610.65
STOP LOSS$488.52
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.27
52W High$567.00
52W Low$456.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $63.51B | $54.47B | $52.03B | $51.61B | $52.32B |
| Gross Profit | $8.96B | $8.45B | $8.13B | $8.12B | $8.07B |
| Gross Margin | 14.1% | 15.5% | 15.6% | 15.7% | 15.4% |
| Operating Income | $293.00M | $916.00M | $1.44B | $1.52B | $1.25B |
| Net Income | $-367,000,000 | $-351,000,000 | $333.00M | $447.00M | $426.00M |
| Net Margin | -0.6% | -0.6% | 0.6% | 0.9% | 0.8% |
| EPS | $-32.42 | $-33.35 | $35.42 | $47.90 | $45.78 |
Company Overview
Pharmarise Holdings Corporation manages dispensing pharmacies in Japan. Its dispensing pharmacies provide patients with dispensing services based on prescriptions drawn up by medical institutions. The company also manages drug stores and convenience stores; and sells cosmetics. In addition, it is involved in the storage and management of medical examination records of patients on behalf of medical institutions; operation of medical mall; and provision of temporary help. As of May 31, 2021, the company operated 347 stores. Pharmarise Holdings Corporation was incorporated in 1984 and is headquartered in Tokyo, Japan.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
2796.TBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-8.36
Q2 2025
EPS Surprise History
Q4 23
No data
Q4 23
No data
Q1 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q1 25
No data
Q2 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Mar 23, 2026 | — | — | — | — |
Q4 2025 | Dec 23, 2025 | — | — | — | — |
Q2 2025 | Jun 26, 2025 | — | $-8.36 | — | — |
Q1 2025 | Mar 24, 2025 | — | $-14.00 | — | — |
Q4 2024 | Dec 23, 2024 | — | $1.59 | — | — |
Q3 2024 | Sep 25, 2024 | — | $-11.65 | — | — |
Q2 2024 | Jun 28, 2024 | — | $-46.94 | — | — |
Q1 2024 | Mar 25, 2024 | — | $-8.36 | — | — |
Q4 2023 | Dec 25, 2023 | — | $15.10 | — | — |
Q4 2023 | Oct 2, 2023 | — | $13.05 | — | — |
Q3 2023 | Jul 11, 2023 | — | $13.26 | — | — |
Q1 2023 | Mar 30, 2023 | — | $14.43 | — | — |
Q4 2022 | Dec 29, 2022 | — | $-4.15 | — | — |
Q4 2022 | Oct 13, 2022 | — | $11.87 | — | — |
Q3 2022 | Jul 8, 2022 | — | $13.46 | — | — |
Q2 2022 | Apr 12, 2022 | — | $7.70 | — | — |
Q1 2022 | Jan 13, 2022 | — | $20.05 | — | — |
Q4 2021 | Oct 14, 2021 | — | $6.78 | — | — |
Q3 2021 | Jul 15, 2021 | — | $33.53 | — | — |
Q2 2021 | Apr 14, 2021 | — | $-1.40 | — | — |
Latest News
Loading news...
Frequently Asked Questions about 2796.T
What is 2796.T's current stock price?
Pharmarise Holdings Corporation (2796.T) is currently trading at $531.00 per share. The stock has moved +0.38% today.
What is the analyst price target for 2796.T?
No analyst price targets are currently available for this stock.
What sector is Pharmarise Holdings Corporation in?
Pharmarise Holdings Corporation operates in the Healthcare sector, specifically within the Medical - Pharmaceuticals industry. The company is traded on the JPX exchange.
What is 2796.T's market cap?
Pharmarise Holdings Corporation has a market capitalization of $6.03 billion, making it a mid-cap company.
Does 2796.T pay dividends?
No, Pharmarise Holdings Corporation does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare Sector190A.T
Chordia Therapeutics Inc.
$106.00
Mkt Cap: $7.3B
206A.T
PRISM BioLab Co.,LTD
$148.00
Mkt Cap: $5.4B
2373.T
Care Twentyone Corporation
$415.00
Mkt Cap: $5.6B
4539.T
Nippon Chemiphar Co., Ltd.
$1542.00
Mkt Cap: $5.6B
4582.T
SymBio Pharmaceuticals Limited
$89.00
Mkt Cap: $4.3B
4883.T
Modalis Therapeutics Corporation
$55.00
Mkt Cap: $4.2B
4891.T
TMS Co., Ltd.
$127.00
Mkt Cap: $5.8B
7079.T
WDB coco Co., Ltd.
$2670.00
Mkt Cap: $6.4B
7707.T
Precision System Science Co., Ltd.
$182.00
Mkt Cap: $4.9B
7980.T
Shigematsu Works Co., Ltd.
$772.00
Mkt Cap: $5.5B
Explore stocks similar to 2796.T for comparison